| RS2230422 |
LBR
|
Health Risk |
Conflicting classifications of pathogenicity |
Greenberg dysplasia, Inborn genetic diseases |
| RS2230516 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 38, Retinitis pigmentosa |
| RS2230532 |
VRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 1A, Pontocerebellar hypoplasia type 1A |
| RS2230723 |
JAK2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2230852 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2230892 |
NDUFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS2230917 |
RRAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome, Noonan syndrome |
| RS2230939 |
F12
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary angioedema type 3, Factor XII deficiency disease |
| RS2231126 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2231137 |
ABCG2
|
Health Risk |
Likely benign; Affects; association |
BLOOD GROUP, JUNIOR SYSTEM |
| RS2231487 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2231488 |
ADA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of adenosine deaminase 2, Autoinflammatory syndrome |
| RS2231678 |
COX15
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Leigh syndrome |
| RS2231682 |
COX15
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, COX15-related disorder |
| RS2231752 |
NECAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 21 |
| RS2231756 |
POLR1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Treacher Collins syndrome 3, POLR1C-related disorder |
| RS2232078 |
FERMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kindler syndrome, Kindler syndrome |
| RS2232207 |
GPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
GPD1-related disorder, GPD1-related disorder |
| RS2232367 |
FOXP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2232387 |
KRT75
|
Health Risk |
Benign; risk factor |
Pseudofolliculitis barbae, KRT75-related disorder |
| RS2232633 |
FLAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2233061 |
MAGEL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2233217 |
MOCS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B, Malignant tumor of urinary bladder |
| RS2233218 |
MOCS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B |
| RS2233289 |
TNIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis, Amyotrophic lateral sclerosis |
| RS2233328 |
NDRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease |
| RS2233466 |
ALG3
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG3-congenital disorder of glycosylation, ALG3-related disorder |
| RS2233583 |
PAX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 9, Type 2 diabetes mellitus |
| RS2233783 |
PROP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pituitary hormone deficiency, combined |
| RS2233787 |
PROP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pituitary hormone deficiency, combined |
| RS2233846 |
RFX5
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class II deficiency, MHC class II deficiency 1 |
| RS2234036 |
SERPINA7
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroxine-binding globulin, variant A |
| RS2234252 |
TREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
TREM2-related disorder, Uterine corpus endometrial carcinoma |
| RS2234333 |
TUBA8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2234473 |
EFEMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, autosomal recessive |
| RS2234581 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, Drash syndrome |
| RS2234584 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, 11p partial monosomy syndrome |
| RS2234663 |
IL1RN
|
Health Risk |
Pathogenic; risk factor |
Gastric cancer susceptibility after h. pylori infection, Microvascular complications of diabetes |
| RS2234675 |
PAX3
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital diaphragmatic hernia, Waardenburg syndrome |
| RS2234693 |
ESR1
|
Health Risk |
risk factor |
Myocardial infarction, susceptibility to |
| RS2234704 |
CRYAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 2, Fatal infantile hypertonic myofibrillar myopathy |
| RS2234916 |
KCNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, drug-associated |
| RS2234917 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease 2 |
| RS2234933 |
CTF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Primary familial hypertrophic cardiomyopathy |
| RS2234936 |
ATP7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, X-linked |
| RS2234939 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS2234980 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS2234998 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2235002 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2235006 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2235011 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2235245 |
HAO1
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS2235250 |
HAO1
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS2235926 |
PADI2
|
Health Risk |
association |
Rheumatoid arthritis, Abnormal pulmonary interstitial morphology |
| RS2236379 |
PRKCQ
|
Health Risk |
Conflicting classifications of pathogenicity |
Inflammatory bowel disease 1, Inflammatory bowel disease 1 |
| RS2236453 |
COL18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Knobloch syndrome, Inborn genetic diseases |
| RS2239671 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, PKD1-related disorder |
| RS2239704 |
LTA
|
Health Risk |
risk factor |
Leprosy, early-onset |
| RS2240340 |
PADI4
|
Health Risk |
association |
Rheumatoid arthritis, Rheumatoid arthritis |
| RS2241116 |
IL18R1
|
Health Risk |
association |
Ascending aortic dissection, Ascending aortic dissection |
| RS2241132 |
IL1RL2
|
Health Risk |
association |
Ascending aortic dissection, Ascending aortic dissection |
| RS2242074 |
CRYGD
|
Health Risk |
Likely pathogenic |
— |
| RS224224 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS2242519 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 28, childhood-onset |
| RS2245425 |
TOR1AIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2Y, Autosomal recessive limb-girdle muscular dystrophy type 2Y |
| RS2255183 |
HAO1
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS2269219 |
FECH
|
Health Risk |
Conflicting classifications of pathogenicity |
Protoporphyria, erythropoietic |
| RS2269577 |
XBP1
|
Health Risk |
risk factor |
-, - |
| RS2271305 |
DDR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome, Connective tissue disorder |
| RS2272070 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS2272457 |
CHD2
|
Health Risk |
Pathogenic |
— |
| RS2272620 |
RAB2A
|
Health Risk |
association |
Vascular endothelial growth factor (VEGF) inhibitor response, Vascular endothelial growth factor (VEGF) inhibitor response |
| RS2272707 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS2272783 |
FECH
|
Health Risk |
Conflicting classifications of pathogenicity |
Protoporphyria, erythropoietic |
| RS2273411 |
ENPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatemic rickets, autosomal recessive |
| RS2273439 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant cerebellar ataxia, Charcot-Marie-Tooth disease axonal type 2O |
| RS2274266 |
COA8
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex IV deficiency, nuclear type 17 |
| RS2274386 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS2274689 |
FBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS2274700 |
CFH
|
Health Risk |
risk factor |
Age related macular degeneration 4, Age related macular degeneration 4 |
| RS2275152 |
IFT80
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Familial cancer of breast |
| RS2275182 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2275402 |
EMC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Inborn genetic diseases |
| RS2275533 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS2275601 |
LBR
|
Health Risk |
Conflicting classifications of pathogenicity |
Greenberg dysplasia, Greenberg dysplasia |
| RS2275602 |
MUTYH;TOE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2276137 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 5, Autosomal recessive spinocerebellar ataxia 14 |
| RS2276263 |
ALG9
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG9 congenital disorder of glycosylation, ALG9 congenital disorder of glycosylation |
| RS2276278 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 11, Usher syndrome type 1 |
| RS2276382 |
TTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Amyloidosis |
| RS2276459 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 1, Type 2 collagenopathy |
| RS2276631 |
SLC11A1
|
Health Risk |
risk factor |
Mycobacterium tuberculosis, susceptibility to infection by |
| RS2276742 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, Connective tissue disorder |
| RS2277202 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Galactosemia |
| RS2277447 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS2277596 |
BBS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 4, Bardet-Biedl syndrome |
| RS2280789 |
CCL5
|
Health Risk |
Pathogenic |
Human immunodeficiency virus type 1, rapid disease progression with infection by |
| RS2282440 |
SDC3
|
Health Risk |
association |
Obesity, association with |
| RS2282983 |
CDK6
|
Health Risk |
association |
Behcet disease, Behcet disease |
| RS2285676 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 13, Hyperinsulinemic hypoglycemia |